Bizzy, for the 37.6% who were on Brilacidin but DI

Bizzy, for the 37.6% who were on Brilacidin but DID develop OM anyway, it may have been of lesser severity or shorter duration. In the first clinical trial, it did shorten the duration for those who developed it.